Various novel erythromycin derivatives obtained by different modifications: Recent advance in macrolide antibiotics

Mini-Reviews in Medicinal Chemistry

Volumn 10, Issue 4, 2010, Pages 272-286

  Ma, C ^a   Ma, S ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Antibacterial activity; Cladinose sugar; Desosamine sugar; Erythromycin resistanct strains; Erythromycin susceptible strains; Erythronolide skeleton; Macrolides; Structural modification

Indexed keywords

11, 12 DI O SUBSTITUTED DERIVATIVE; 3 O DESCLADINOSYL DERIVATIVE; 3, 6 BICYCLOLIDE; 6 O SUBSTITUTED DERIVATIVE; 9 O SUBSTITUTED DERIVATIVE; CARBAMIC ACID DERIVATIVE; CARBONIC ACID DERIVATIVE; ERYTHROMYCIN DERIVATIVE; ERYTHRONOLIDE DERIVATIVE; MACROLIDE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CLADINOSE; DRUG DERIVATIVE; ERYTHROMYCIN; HEXOSE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CHEMICAL MODIFICATION; DRUG ACTIVITY; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; STRUCTURE ACTIVITY RELATION; CHEMISTRY; REVIEW;

ANTI-BACTERIAL AGENTS; ERYTHROMYCIN; HEXOSES; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77956625393     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955710791331025     Document Type: Article

References (24)

1. Elliott, R. L.; Pireh, D.; Griesgraber, G.; Nilius, A. M.; Ewing, P. J.; Bui, M. H.; Raney, P. M.; Flamm, R.K.; Kim, K.; Henry, R. F.; Chu, D. T. W.; Plattner, J. J.; Or, Y. S. Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues. J. Med. Chem., 1998, 41, 1651-1659.
2. Tanikawa, T.; Asaka, T.; Kashimura, M.; Misawa, Y.; Suzuki, K.; Sato, M.; Kameo, K.; Morimoto, S.; Nishida, A. Synthesis and antibacterial activity of acylides (3-O-acyl-erythromycin derivatives): a novel class of macrolide antibiotics. J. Med. Chem., 2001, 44, 4027-4030.
3. Tanikawa, T.; Asaka, T.; Kashimura, M.; Suzuki, K.; Sugiyama, H.; Sato, M.; Kameo, K.; Morimoto, S.; Nishida, A. Synthesis and antibacterial activity of a novel series of acylides: 3-O-(3-pyridyl) acetylerythromycin A derivatives. J. Med. Chem., 2003, 46, 2706-2715.
4. Pandey, D.; Haq, W.; Katti, S. B. New acylides: synthesis of 3-O-[γ(4-oxo-2-aryl-thiazolidin-3-yl) butyryl]erythromycin A derivatives. Beilstein J. Org. Chem., 2008, 4, 1-5.
5. Tang, D. T.; Gai, Y. H.; Polemeropoulos, A.; Chen, Z. G.; Wang, Z.; Or, Y. S. Design, synthesis, and antibacterial activities of novel 3,6-bicyclolide oximes: Length optimization and zero carbon linker oximes. Bioorg. Med. Chem. Lett., 2008, 18, 5078-5082
6. Gai, Y. H.; Tang, D. T.; Xu, G. Y.; Chen, Z. G.; Polemeropoulos, A.; Wang, Z.; Or, Y. S. Synthesis of 3,6-bicyclolides: A novel class of macrolide antibiotics. Bioorg. Med. Chem. Lett., 2008, 18, 6315-6318.
7. Heggelund, A.; Undheim, K. Descladinosyl erythromycin in phosgene-assisted cyclic 3,6-ether formation. Tetrahedron Lett., 2008, 5569-5571.
8. Xu, P.; Liu, L.; Jin, Z. P.; Lei, P. S. Synthesis and antibacterial activity of derivatives of 6-O-allylic acylides. Bioorg. Med. Chem. Lett., 2007, 17, 3330-3334.
9. Zhu, B.; Marinelli, B. A.; Abbanat, D.; Foleno, B. D.; Bush, K.; Macielag, M. J. Synthesis and antibacterial activity of 3-keto-6-Ocarbamoyl-11,12-cyclic thiocarbamate erythromycin A derivatives. Bioorg. Med. Chem. Lett., 2007, 17, 3900-3904.
10. Dondas, H. A.; Yaktubay, N. Synthesis of two and antibacterial activity of one novel oxime ether derivatives of erythromycin A. Farmaco, 2003, 58, 1011-1015.
11. Ištuk, Z. M.; Mutak, S.; Kujundžić, N.; Kragol, G. Novel 9acarbamoyl-and 9a-thiocarbamoyl-3-decladinosyl-6-hydroxy and 6-methoxy derivatives of 15-membered macrolides. Bioorg. Med. Chem., 2007, 15, 4498-4510.
12. Bukvić, M.; Krajaić Novak, P.; Cindrić, M.; Brajša, K.; Dumić, M.; Kujundžić, N. Azithromycin-sulfonamide conjugates as inhibitors of resistant Streptococcus pyogenes strains. Eur. J. Med. Chem., 2007, 42, 138-145.
13. Pandey, D.; Katti, S. B.; Haqa, W.; Tripathi, C. K. M. Synthesis and antimicrobial activity of erythromycin A oxime analogs. Bioorg. Med. Chem., 2004, 12, 3807-3813.
14. Sugawara, A.; Sunazuka, T.; Hirose, T.; Nagai, K.; Yamaguchi, Y.; Hanaki, H.; Sharplessb, K. B.; Omura, S. Design and synthesis via click chemistry of 8,9-anhydroerythromycin A 6,9-hemiketal analogues with anti-MRSA and -VRE activity. Bioorg. Med. Chem. Lett., 2007, 17, 6340-6344.
15. Sherman, D.; Xiong, L. Q.; Mankin, A. S.; Melman, A. Synthesis and biological investigation of new 4"-malonyl tethered derivatives of erythromycin and clarithromycin. Bioorg. Med. Chem. Lett., 2006, 16, 1506-1509.
16. Li, J.; Kim, I. H; Roche, E. D.; Beeman, D.; Lynch, A. S.; Dinga, C. Z.; Ma, Z. K. Design, synthesis, and biological evaluation of BODIPY-erythromycin probes for bacterial ribosomes. Bioorg. Med. Chem. Lett., 2006, 16, 794-797.
17. Xu, P.; Liu, L.; Jin, Z. P.; Wang, G. Q.; Liu, J.; Li, Y.; Lei, P. S. Synthesis and antibacterial activity of 4"-O-heteroarylcarbamoyl derivatives of macrolide. Bioorg. Med. Chem. Lett., 2008, 18, 5507-5511.
18. Xian, R. Q.; Ma, S. T.; Jiao, B. Synthesis of novel 15-membered macrolide derivatives. Chin. Chem. Lett., 2008, 19, 409-411.
19. Ma, S. T.; Jiao, B; Liu, Z. P.; Wang, H.; Xian, R. Q.; Zheng, M. J.; Lou, H. X. Synthesis and antibacterial activity of 4",11-di-Oarylalkylcarbamoyl azithromycin derivatives. Bioorg. Med. Chem. Lett., 2009, 19, 1698-1701.
20. Heggelund, A.; Undheim, K. Preparation of cyclic 2',3'-carbamate derivatives of erythromycin macrolide antibiotics. Bioorg. Med. Chem., 2007, 15, 3266-3277.
21. Heggelund, A.; Rømming, C.; Undheim, K. Preparation and antibacterial activity of cyclic 2',3'-carbamate derivatives of azithromycin. Eur. J. Med. Chem., 2008, 43, 1657-1664.
22. Oyelere, A. K.; Chen, P. C.; Guerrant, W.; Mwakwari, S. C.; Hood, R.; Zhang, Y. Z.; Fan, Y. H. Non-peptide macrocyclic histone deacetylase inhibitors. J. Med. Chem., 2009, 52, 456-468.
23. Randolph J. T.; Waid P.; Nichols C.; Sauer D.; Haviv F.; Diaz G; Bammert, G.; Besecke, L. M.; Segreti, J. A.; Mohning, K. M.; Bush, E. N.; Wegner, C. D.; Greer, J. Nonpeptide luteinizing hormone-releasing hormone antagonists derived from erythromycin A: design, synthesis,and biological activity of cladinose replacement analogues. J. Med. Chem., 2004, 47, 1085-1097.
24. Mereu, A.; Moriggi, E.; Napoletano, M.; Regazzoni, C.; Manfredini, S.; Mercurio, T. P.; Pellacini, F. Design, synthesis and in vivo activity of 9-(S)-dihydroerythromycin derivatives as potent antiinflammatory agents. Bioorg. Med. Chem. Lett., 2006, 16, 5801-5804.